FDA Alerts Hospitals, Labs, Others About Recall of Beckman Coulter Blood Test Analyzers
May 23 2019 - 2:39PM
Dow Jones News
By Stephen Nakrosis
The U.S. Food and Drug Administration said Thursday it is
alerting hospitals, laboratories and providers about an earlier
recall of some blood diagnostics devices sold by Beckman Coulter, a
manufacturer of medical diagnostics products.
The FDA said the Class 1 recall covers Beckman Coulter DxH 800,
DxH 600 and DxH 900 hematology analyzers.
The recall relates to the devices' platelet analyzing function,
the FDA said, adding the company hasn't received complaints about
other of these devices' functions.
The FDA said its latest action is an update to an urgent medical
device correction letter first issued by Beckman Coulter in 2018.
Beckman Coulter notified its customers in August of that year they
had been informed of erroneously elevated platelet results that
were occurring without error messages, the FDA said.
The FDA said Beckman Coulter has indicated to customers a
software update to the device may serve to alert laboratory
personnel to any inaccurate results, but the agency hasn't
evaluated the software. It is currently working with the company to
determine if the software update alone is adequate to address the
recall.
The FDA said it is aware of more than 2,000 laboratories in the
U.S. that may be affected.
Danaher Corp. (DHR) is the parent organization of Beckman
Coulter.
Beckman Coulter didn't immediately respond to a request for
comment.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
May 23, 2019 14:24 ET (18:24 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Sep 2023 to Sep 2024